JP2014524936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524936A5 JP2014524936A5 JP2014523106A JP2014523106A JP2014524936A5 JP 2014524936 A5 JP2014524936 A5 JP 2014524936A5 JP 2014523106 A JP2014523106 A JP 2014523106A JP 2014523106 A JP2014523106 A JP 2014523106A JP 2014524936 A5 JP2014524936 A5 JP 2014524936A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- pharmaceutically acceptable
- prodrug
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CN1C(OC*)SCC1C(O)=O Chemical compound CN1C(OC*)SCC1C(O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512751P | 2011-07-28 | 2011-07-28 | |
| US61/512,751 | 2011-07-28 | ||
| PCT/US2012/048820 WO2013016727A1 (en) | 2011-07-28 | 2012-07-30 | Cysteine prodrugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014524936A JP2014524936A (ja) | 2014-09-25 |
| JP2014524936A5 true JP2014524936A5 (enExample) | 2015-09-03 |
Family
ID=47601579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523106A Pending JP2014524936A (ja) | 2011-07-28 | 2012-07-30 | システインプロドラッグ |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9457014B2 (enExample) |
| EP (1) | EP2736890A4 (enExample) |
| JP (1) | JP2014524936A (enExample) |
| CA (1) | CA2842106A1 (enExample) |
| WO (1) | WO2013016727A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2736890A4 (en) * | 2011-07-28 | 2015-07-15 | Promentis Pharm Inc | Cysteine PRODRUGS |
| US20130338165A1 (en) * | 2012-06-15 | 2013-12-19 | Promentis Pharmaceuticals, Inc. | Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease |
| US20150045312A1 (en) * | 2013-08-12 | 2015-02-12 | Promentis Pharmaceuticals, Inc. | Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome |
| EP3066089B1 (en) | 2013-11-08 | 2019-11-06 | Promentis Pharmaceuticals, Inc. | Substituted n-acetyl-l-cysteine derivatives and related compounds |
| AU2015317877A1 (en) * | 2014-09-15 | 2017-05-04 | Sound Pharmaceuticals Incorporated | Methods and compositions for treating psychotic disorders |
| SMT202400469T1 (it) | 2016-05-18 | 2025-01-14 | Sound Pharmaceuticals Incorporated | Ebselen per l'uso nel trattamento della malattia di ménière |
| PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
| CN110087641B (zh) | 2016-12-20 | 2024-03-12 | 罗曼治疗系统股份公司 | 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统 |
| JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
| CN112236138B (zh) | 2017-12-05 | 2024-05-31 | 赛诺维信制药公司 | 晶体形式及其制备方法 |
| AU2018379992B2 (en) | 2017-12-05 | 2022-07-21 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| CN118806732A (zh) | 2018-06-20 | 2024-10-22 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
| CA3124825A1 (en) * | 2018-12-31 | 2020-07-09 | Zymergen Inc. | Polymer compositions comprising compounds derived from biology |
| CA3142355A1 (en) | 2019-06-04 | 2020-12-10 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| CN113024473B (zh) * | 2021-04-13 | 2022-08-23 | 陕西慧康生物科技有限责任公司 | 一种含有半胱氨酸的环二肽的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT995110B (it) * | 1973-08-01 | 1975-11-10 | Snam Progetti | Procedimento per la produzione di composti eterociclici e prodotti ottenuti |
| JPS6016989A (ja) | 1983-07-06 | 1985-01-28 | Shionogi & Co Ltd | オキソ飽和異項環カルボンアミドセフエム化合物 |
| AU647599B2 (en) * | 1991-03-27 | 1994-03-24 | Sankyo Company Limited | New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators |
| AU682894B2 (en) | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| CA2419845A1 (en) * | 1999-08-17 | 2002-02-22 | Phyllis G. Paterson | Improved treatment for acute physical insult to the central nervous system |
| US7829709B1 (en) * | 2007-08-10 | 2010-11-09 | Marquette University | Cysteine prodrugs to treat schizophrenia and drug addiction |
| US8173809B2 (en) * | 2008-02-07 | 2012-05-08 | Marquette University | Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| EP2736890A4 (en) * | 2011-07-28 | 2015-07-15 | Promentis Pharm Inc | Cysteine PRODRUGS |
-
2012
- 2012-07-30 EP EP12817817.5A patent/EP2736890A4/en not_active Withdrawn
- 2012-07-30 JP JP2014523106A patent/JP2014524936A/ja active Pending
- 2012-07-30 US US14/391,785 patent/US9457014B2/en active Active
- 2012-07-30 CA CA2842106A patent/CA2842106A1/en active Pending
- 2012-07-30 WO PCT/US2012/048820 patent/WO2013016727A1/en not_active Ceased
-
2016
- 2016-06-06 US US15/174,410 patent/US20160287563A1/en not_active Abandoned